Send feedback

PGAP2 p.Glu131fs

c.391dup · rs1590414565 · VCV802650

Uncertain significance Single submitter
Classification
Uncertain significance
ClinVar
Review
Single submitter ★☆☆☆
ClinVar · 1 submitter
Consequence
frameshift
predicted LoF
gnomAD v4.1
Rare
very rare (popmax 0.00017%, nfe)
Conditions
1
hyperphosphatasia with intellectual disability syndrome 3

Computational evidence

Protein change
Missense predictors do not apply to this variant type; conservation carries the signal.
Consequenceframeshiftpredicted loss-of-function
NMDpredictedpremature termination codon in exon 4 of 7
Splicing
SpliceAI—not assessed · substitutions only
Constraint at this position
ConservationphyloP -7.1GERP -3.7

Predicted loss-of-function is descriptive, not an applied PVS1 code.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.00017% European (non-Finnish) · 2/1,179,850 alleles
Filtering AF 2.8e-05% ClinGen BA1/BS1 input FAF95, joint · FAF99 1.1e-05%
Overall 0.000187% 3/1,603,026 alleles · very rare exomes 3/1,450,836 · genomes 0/152,190 · joint denominator
Ancestry group Frequency 1 in
Ashkenazi Jewishnot grpmax-eligible 0.00338% 29,592
European (non-Finnish)grpmax 0.00017% 589,925

Ashkenazi Jewish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
PGAP2
Protein
p.Glu131fs
Coding
c.391dup
MANE Select
NM_014489
dbSNP
rs1590414565
Type
Duplication
Location
chr11:3823921 (GRCh38)
Gene constraint
LOEUF 0.871 · pLI <0.01 (gnomAD)
Structure
AlphaFold pLDDT 90.00
Full PGAP2 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

hyperphosphatasia with intellectual disability syndrome 3 — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

For Hyperphosphatasia-intellectual disability syndrome (Orphanet):

Inheritance
Autosomal recessive
Onset
Infancy, Neonatal

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/pgap2-p-glu131fs (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown